Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06662279 · ClinicalTrials.gov registry record · NA
Hyrax Vs. Invisalign Palatal Expander Clinical Study
A NA study of Malocclusions and Narrow Maxilla, sponsored by Align Technology.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 4
- Study locations
NCT06662279: Recruiting NA study of Malocclusions and Narrow Maxilla, sponsored by Align Technology.
NCT06662279 is a NA study of Malocclusions and Narrow Maxilla that is actively recruiting participants, run by Align Technology. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06662279, a NA study of Malocclusions and Narrow Maxilla, is actively recruiting participants, sponsored by Align Technology.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to compare expansion result and the overall experience between the Invisalign Palatal Expander and the Hyrax expander.
Primary Outcome
intraoral scans will be taken of the subject's upper arch, including palate throughout the study and widths will be measured
Conditions Studied
Interventions
- DEVICE Removable Rapid Palatal Expander
- DEVICE Banded Palatal Expander
Study Locations (4)
California
- Orange Coast Orthodontics - Laguna Hills
Georgia
- Spillers Orthodontics - Warner Robins
Illinois
- Innovative Orthodontic Centers - Naperville
Maryland
- The Orthodontic Studio - Chevy Chase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-10-25 |
| Est. Completion | 2026-01 |
| Phase | NA |
What NCT06662279 shows while recruiting
NCT06662279 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with Malocclusions appearing as the primary indexed condition, and to 2 interventions - of which Removable Rapid Palatal Expander is the first listed.
NCT06662279 reports a single indexed study location in California, Georgia, Illinois.
Frequently Asked Questions
What is clinical trial NCT06662279 about?
NCT06662279 is a clinical study titled "Hyrax Vs. Invisalign Palatal Expander Clinical Study". The purpose of this study is to compare expansion result and the overall experience between the Invisalign Palatal Expander and the Hyrax expander.
What is the current status of trial NCT06662279?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2024-10-25. Estimated completion is 2026-01.
What conditions does trial NCT06662279 study?
This clinical trial studies the following conditions: Malocclusions, Narrow Maxilla, Narrow Maxillary Arch, Crowding.
What interventions are being tested in trial NCT06662279?
The interventions under investigation include: Removable Rapid Palatal Expander (DEVICE), Banded Palatal Expander (DEVICE).
Who is sponsoring clinical trial NCT06662279?
This trial is sponsored by Align Technology, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06662279 being conducted?
This trial has 4 study locations across California, Georgia, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06662279's enrollment target sits among peer trials
36 1542nd of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI